D. Neil Hayes

97.8k citations

221 papers · 11.5k indexed · 3 hit papers · h-index 47

Molecular Biology top 1%
Oncology top 0.5%
Pulmonary and Respiratory Medicine top 0.5%
Cancer Research top 0.2%
Otorhinolaryngology top 0.1%

Co-authors: Matthew D. Wilkerson Charles M. Perou Marion E. Couch Mark C. Weissler Joel S. Parker Bhishamjit S. Chera J. S. Marron Matthew Meyerson
Topics: Head and Neck Cancer Studies (78 papers)Lung Cancer Treatments and Mutations (50 papers)Cancer Genomics and Diagnostics (33 papers)
Cited by: Otorhinolaryngology Cancer Research Oncology
Journals: Nature Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United States Canada France

In The Last Decade

D. Neil Hayes

213 papers receiving 11.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

2010 3.5k citations Matthew D. Wilkerson, D. Neil Hayes profile →
Menin Associates with a Trithorax Family Histone Methyltransferase Complex and with the Hoxc8 Locus

2004 504 citations D. Neil Hayes, Matthew Meyerson et al. profile →
Long‐term Survival in Head and Neck Cancer: Impact of Site, Stage, Smoking, and Human Papillomavirus Status

2019 175 citations Mark C. Weissler, D. Neil Hayes et al. profile →

Peers

Countries citing papers authored by D. Neil Hayes

Since Specialization

Citations

This map shows the geographic impact of D. Neil Hayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Neil Hayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Neil Hayes more than expected).

Fields of papers citing papers by D. Neil Hayes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Neil Hayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Neil Hayes. The network helps show where D. Neil Hayes may publish in the future.

Co-authorship network of co-authors of D. Neil Hayes

This figure shows the co-authorship network connecting the top 25 collaborators of D. Neil Hayes. A scholar is included among the top collaborators of D. Neil Hayes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Neil Hayes. D. Neil Hayes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer 2023 ·Biomedicines ·Farhan Khan,(unknown),(unknown),(unknown),Gary Price,Daniel L. Johnson,Suriyan Ponnusamy,(unknown),(unknown),Jay H. Fowke,D. Neil Hayes,Ramesh Narayanan	1
2	A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer 2023 ·Annals of Oncology ·Ari J. Rosenberg,(unknown),Theodore Karrison,Jonas A. de Souza,(unknown),(unknown),Monika K. Krzyzanowska,D. Neil Hayes,Eric Winquist,(unknown),(unknown),Victoria Villaflor,Tanguy Y. Seiwert,Rebecca B. Schechter,Walter M. Stadler,Ezra E.W. Cohen,Everett E. Vokes	2
3	Unsupervised Hierarchical Clustering of Head and Neck Cancer Patients by Pre-Treatment Plasma Metabolomics Creates Prognostic Metabolic Subtypes 2023 ·Cancers ·Ronald C. Eldridge,Zhaohui Qin,Nabil F. Saba,Madelyn C. Houser,D. Neil Hayes,Andrew H. Miller,Deborah Watkins Bruner,Dean P. Jones,Canhua Xiao	2
4	Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients 2023 ·The Pharmacogenomics Journal ·Nancy Gillis,Amy S. Etheridge,(unknown),D. Neil Hayes,Michele C. Hayward,J. Todd Auman,Joel S. Parker,Federico Innocenti	2
5	Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient Survival 2021 ·Cancer Epidemiology Biomarkers & Prevention ·Ronald C. Eldridge,Karan Uppal,D. Neil Hayes,Matthew Ryan Smith,Xin Hu,Zhaohui Qin,Jonathan J. Beitler,Andrew H. Miller,Evanthia C. Wommack,Kristin Higgins,Dong M. Shin,Bryan C. Ulrich,David C. Qian,Nabil F. Saba,Deborah Watkins Bruner,Dean P. Jones,Canhua Xiao	5
6	SCISSOR: a framework for identifying structural changes in RNA transcripts 2021 ·Nature Communications ·(unknown),Heejoon Jo,Xiaobei Zhao,Katherine A. Hoadley,Scott Newman,(unknown),Michele C. Hayward,Michael I. Love,J. S. Marron,D. Neil Hayes	6
7	Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma 2020 ·Clinical Cancer Research ·(unknown),Vonn Walter,Xiaoying Yin,David Marron,Matthew D. Wilkerson,(unknown),Xiaobei Zhao,Heejoon Jo,D. Neil Hayes,Yoon Ho Ko	9
8	Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non–Small Cell Lung Carcinoma 2020 ·Molecular Cancer Research ·Shujie Song,Vinh Nguyen,Travis P. Schrank,Kathleen M. Mulvaney,Vonn Walter,Darmood Wei,(unknown),(unknown),Jiren Zhang,D. Neil Hayes,Yanfang Zheng,Michael B. Major,Bernard E. Weissman	26
9	Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication 2020 ·Clinical Cancer Research ·Jared Weiss,Siddharth Sheth,Allison M. Deal,Juneko E. Grilley‐Olson,Samip Patel,Trevor Hackman,Jeffrey M. Blumberg,Thomas J. Galloway,Shetal Patel,Adam M. Zanation,Colette J. Shen,D. Neil Hayes,Christopher Hilliard,Ranee Mehra,Karen P. McKinnon,Hsing‐Hui Wang,Mark C. Weissler,Jessica R. Bauman,Bhishamjit S. Chera,Benjamin G. Vincent	29
10	MVisAGe Identifies Concordant and Discordant Genomic Alterations of Driver Genes in Squamous Tumors 2018 ·Cancer Research ·Vonn Walter,Ying Du,Ludmila Danilova,Michele C. Hayward,D. Neil Hayes	6
11	Initial Results from a Phase 2 Prospective Trial of De-intensified Chemoradiation therapy for Low-Risk HPV-associated Oropharyngeal Squamous Cell Carcinoma 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Bhisham Chera,Robert J. Amdur,Colette J. Shen,Xianming Tan,D. Neil Hayes,Jared Weiss,Juneko E. Grilley‐Olson,Adam M. Zanation,Trevor Hackman,José P. Zevallos,Samip Patel,Nathan Sheets,Mark C. Weissler,William M. Mendenhall	2
12	Molecular Evolution Patterns in Metastatic Lymph Nodes Reflect the Differential Treatment Response of Advanced Primary Lung Cancer 2016 ·Cancer Research ·Sang‐Won Um,Je‐Gun Joung,Hyun Lee,Hojoong Kim,Kyu-Tae Kim,Jinha Park,D. Neil Hayes,Woong‐Yang Park	12
13	A Prospective Phase II Trial of Deintensified Chemoradiation Therapy for Low Risk HPV Associated Oropharyngeal Squamous Cell Carcinoma 2015 ·International Journal of Radiation OncologyBiologyPhysics ·Bhishamjit S. Chera,Robert J. Amdur,Joel E. Tepper,Bahjat F. Qaqish,(unknown),D. Neil Hayes,Jared Weiss,Juneko E. Grilley‐Olson,Adam M. Zanation,Trevor Hackman,William K. Funkhouser,Nathan Sheets,Mark C. Weissler,William M. Mendenhall	4
14	BRG1/SMARCA4 Inactivation Promotes Non–Small Cell Lung Cancer Aggressiveness by Altering Chromatin Organization 2014 ·Cancer Research ·(unknown),Austin J. Hepperla,Vonn Walter,Shujie Song,Jeremy M. Simon,Joel S. Parker,Matthew D. Wilkerson,Nisarg Desai,Michael B. Major,D. Neil Hayes,Ian J. Davis,Bernard E. Weissman	102
15	Gene Silencing Associated with SWI/SNF Complex Loss during NSCLC Development 2014 ·Molecular Cancer Research ·Shujie Song,Vonn Walter,Mehmet Karaca,Ying Li,(unknown),Dominic J. Smiraglia,Daniel Serber,(unknown),Christoph Plass,Jiren Zhang,D. Neil Hayes,Yanfang Zheng,Bernard E. Weissman	20
16	Hedgehog–GLI Signaling Inhibition Suppresses Tumor Growth in Squamous Lung Cancer 2014 ·Clinical Cancer Research ·Lingling Huang,Vonn Walter,D. Neil Hayes,Mark W. Onaitis	92
17	Cancer-Derived Mutations in KEAP1 Impair NRF2 Degradation but not Ubiquitination 2013 ·Cancer Research ·Bridgid E. Hast,Erica W. Cloer,Dennis Goldfarb,Heng Li,Priscila F. Siesser,Feng Yan,Vonn Walter,Ning Zheng,D. Neil Hayes,Michael B. Major	100
18	Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma 2013 ·Cancer Research ·Rachel G. Liao,Joonil Jung,Jeremy H. Tchaicha,Matthew D. Wilkerson,Andrey Sivachenko,Ellen M. Beauchamp,Qingsong Liu,Trevor J. Pugh,Chandra Sekhar Pedamallu,D. Neil Hayes,Nathanael S. Gray,Gad Getz,Kwok‐Kin Wong,Robert I. Haddad,Matthew Meyerson,Peter S. Hammerman	134
19	Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements 2012 ·Clinical Cancer Research ·D. Neil Hayes,(unknown),Tawee Tanvetyanon,Monika K. Krzyzanowska,Christine H. Chung,Barbara A. Murphy,Jill Gilbert,Ranee Mehra,Dominic T. Moore,Arif Sheikh,Janelle M. Hoskins,Michele C. Hayward,Ni Zhao,(unknown),Karen E. Weck,Roger B. Cohen,Ezra E.W. Cohen	120
20	Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types 2010 ·Clinical Cancer Research ·Matthew D. Wilkerson,Xiaoying Yin,Katherine A. Hoadley,Yufeng Liu,Michele C. Hayward,Christopher R. Cabanski,Kenneth L. Muldrew,C. Ryan Miller,Scott H. Randell,Mark A. Socinski,Alden M. Parsons,William K. Funkhouser,Carrie B. Lee,Patrick J. Roberts,Leigh B. Thorne,Philip S. Bernard,Charles M. Perou,D. Neil Hayes	194

About D. Neil Hayes

D. Neil Hayes is a scholar working on Otorhinolaryngology, Cancer Research and Oncology, having authored 221 papers that have together received 11.5k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (78 papers), Lung Cancer Treatments and Mutations (50 papers) and Cancer Genomics and Diagnostics (33 papers). The work is most often cited by research in Otorhinolaryngology (1.7k citations), Cancer Research (3.1k citations) and Oncology (3.5k citations). D. Neil Hayes has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Matthew D. Wilkerson, Charles M. Perou, Marion E. Couch, Mark C. Weissler, Joel S. Parker, Bhishamjit S. Chera, J. S. Marron, Matthew Meyerson, Vonn Walter and Mark A. Socinski. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact